Survey: 71% of CBD users self-determine dosage without consulting a professional

By Danielle Masterson

- Last updated on GMT

Getty Images /  Luke Chan
Getty Images / Luke Chan
Although the 2018 Farm Bill legalized the use of hemp and its products, it didn’t amend the Food, Drug and Cosmetic Act to permit the use of hemp or hemp-derived products in dietary supplements. This lack of oversight has left a gaping hole in the industry, with brands and consumers left to interpret CBD dosing themselves.

Last year representatives Kurt Schrader (D-OR) and Morgan Griffith (R-VA) introduced the Hemp and Hemp-Derived CBD Consumer Protection & Market Stabilization Act. In February, Rep. Schrader re-introduced the bill, which aims to allow CBD and other hemp-derived products to lawfully be used in dietary supplements under the Federal Food, Drug and Cosmetic Act. This bill prioritizes consumer safety, requiring manufacturers to comply with existing federal regulations for dietary supplements and ensuring that products are properly labelled and prepared. 

Standardization 

CBD regulations would also help standardize safe amounts of CBD. Because consumers often reach for CBD for a multitude of effects, dosage depends on not only what benefit consumers are seeking, but also format, bioavailability and genetic factors such as microbiome health. 

With no uniformity for dosing, Leafreport decided to ask consumers how they gauge CBD amounts​. Via SurveyMonkey, the consumer watchdog group surveyed over a thousand individuals in the US. Those who hadn’t used CBD before were disqualified from the survey, leaving 721 participants remaining.

Key Findings

  • 71% determined the dosage themselves without consulting a professional
  • 26% do not check for CBD concentration when shopping for CBD products
  • 22% do not check the dose before taking CBD
  • 29% of CBD users consulted with a professional to determine dosage
  • 48% tend to take the same dosage every time they consume CBD
  • 31% use CBD for pain
  • 26.5% use CBD for anxiety/stress
  • 18% use CBD for sleep
  • 12.5% use CBD for depression 
  • 31% use CBD daily 

Leafreport noted that in many cases, CBD was being used to help with multiple conditions, such as depression and insomnia simultaneously.

Consumer preference 

When it comes to format, the survey revealed that 35% of respondents favored CBD-infused gummies, edibles, and beverages. Just over a quarter reports that they prefer oils and tinctures, followed by topicals coming in at 14%, and capsules at 12%. Just 10% of users said they vaped their CBD.

When buying CBD, many respondents indicated they weren’t necessarily looking for products with super high concentrations of CBD. Thirty-two percent said they sought out products containing 500mg-1000mg of CBD, 28% looked for products with less than 500 mg, 26% admitted that they didn’t check for CBD concentration, 9% desired products containing 1001-2500mg, and 5% sought potent CBD products with more than 2500 mg.

Dosage

Image courtesy of Leafreport

Not surprisingly, dosage was all over the map, with 26% of respondents reporting that they take 5-10 mg and 22% admitting  they didn’t know how much they take because they didn’t check the dose.

About 17% of respondents said they took 10-20 mg, while 13% took less than 5 mg. 11% of the respondents took 20-40 mg, and a further 4% took 40-70 milligrams. Another 4% took more than 100 mg each time and 3% took 70-100 mg. 

When asked who recommended this dosage, 42% said they determined the dosage themselves based on trial and error. Just over 20% reported that they followed the dosage guidelines on the product.

Some respondents did seek out an expert, with 18% consulting, 11% discussing dosage with a cannabis industry professional and 8% either researching online or using a dosage calculator.

Satisfaction 

A majority (57%) of respondents indicated that they were satisfied with the dose, while 17% said they were not happy and had increased the dosage over time, followed by 16% who are still looking to achieve the right dosage and 10% actually decreased the dosage because the effects were too strong.

Due to the lack of standardized safe amounts of CBD, Leafreport created a dosing guide​ and recommends consumers take the “start low, go slow” approach.

Related news

Show more

Related products

show more

Zone In With Cognizin®

Zone In With Cognizin®

Content provided by Kyowa Hakko (US) | 08-Jul-2024 | White Paper

Did you know 53% of U.S. cognitive health consumers are interested in beverages for cognitive health?

11 Important Aspects of US Food Regulations

11 Important Aspects of US Food Regulations

Content provided by SGS Nutrasource | 25-Jun-2024 | White Paper

Are you navigating the complex world of regulatory affairs to ensure ingredient and product compliance? We are delighted to present our FAQ guide, reviewed...

Related suppliers

Follow us

Products

View more

Webinars